These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18078012)

  • 21. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
    Liao JK
    Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of HMG-CoA Reductase: Current and Future Prospects.
    Singh N; Tamariz J; Chamorro G; Medina-Franco JL
    Mini Rev Med Chem; 2009 Oct; 9(11):1272-83. PubMed ID: 19929805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the inflammatory process by statins.
    Crisby M
    Timely Top Med Cardiovasc Dis; 2005 Mar; 9():E3. PubMed ID: 15824762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pitavastatin: an overview.
    Saito Y
    Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
    Manzoni M; Rollini M
    Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.
    Stefanutti C; Morozzi C; Di Giacomo S
    Curr Med Chem; 2012; 19(28):4861-8. PubMed ID: 22963620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
    J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro.
    Correll CC; Edwards PA
    J Biol Chem; 1994 Jan; 269(1):633-8. PubMed ID: 8276863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid chromatography-tandem mass spectrometry method for the measurement of serum mevalonic acid: a novel marker of hydroxymethylglutaryl coenzyme A reductase inhibition by statins.
    Waldron J; Webster C
    Ann Clin Biochem; 2011 May; 48(Pt 3):223-32. PubMed ID: 21355014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and ischaemia reperfusion injury: a molecular biological review.
    Abdul Rahman MN; Chetter IC
    Curr Vasc Pharmacol; 2010 Nov; 8(6):831-5. PubMed ID: 19485917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleiotropic effects of statins: A focus on cancer.
    Ahmadi M; Amiri S; Pecic S; Machaj F; Rosik J; Łos MJ; Alizadeh J; Mahdian R; da Silva Rosa SC; Schaafsma D; Shojaei S; Madrakian T; Zeki AA; Ghavami S
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165968. PubMed ID: 32927022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Mediterranean-style, low-glycemic-load diet reduces the expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in mononuclear cells and plasma insulin in women with metabolic syndrome.
    Jones JL; Park Y; Lee J; Lerman RH; Fernandez ML
    Nutr Res; 2011 Sep; 31(9):659-64. PubMed ID: 22024489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
    J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.